Kewaunee Scientific Q2 FY2025: Sales down 5.3%, diluted EPS $1.01 vs $0.93 YoY; backlog record $184.4M

KEWAUNEE SCIENTIFIC CORP /DE/

2025-Q2 EPS reported $1.75 revenue$96,157,000

Net sales $47.8M (down 5.3% YoY); domestic sales up 6.5%, international down 30.1% due to India construction delays.
Diluted EPS $1.01 vs $0.93 YoY; net earnings $3.0M vs $2.7M; EBITDA $4.9M.
Record backlog $184.4M (Oct 31, 2024) vs $146.3M a year ago and $155.6M at April 30, 2024.
Domestic segment net earnings $4.5M (up from $3.1M); international net earnings $0.4M (down from $0.5M).
Incurred $2.3M in acquisition-related expenses for Nu Aire (closed Nov 1, 2024); adjusted diluted EPS would be $1.41.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.